Statement of Changes in Beneficial Ownership (4)

FORM 4

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL

OMB Number:

3235-0287

Estimated average burden
hours per response...

0.5

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person * Hartman Curt R	2. Issuer Name and Ticker or Trading Symbol CONMED CORP [ CNMD ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) __X__ Director                    _____ 10% Owner __X__ Officer (give title below)    _____ Other (specify below) President & CEO
(Last)          (First)          (Middle) C/O CONMED CORP, 525 FRENCH ROAD	3. Date of Earliest Transaction (MM/DD/YYYY) 1/31/2020
(Street) UTICA, NY 13502 (City)        (State)        (Zip)	4. If Amendment, Date Original Filed (MM/DD/YYYY)	6. Individual or Joint/Group Filing (Check Applicable Line) _X _ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security (Instr. 3)	2. Trans. Date	2A. Deemed Execution Date, if any	3. Trans. Code (Instr. 8)		4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	1/31/2020		M		104000	A	(1)	150704	D
Common Stock	1/31/2020		F		48903	D	$101.68	101801	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Trans. Date	3A. Deemed Execution Date, if any	4. Trans. Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
PSUs (Performance Stock Units)	$0	1/31/2020		A		104000		1/31/2020	(1)	Common Stock	104000	$0	104000	D
PSUs (Performance Stock Units)	$0	1/31/2020		M			104000	1/31/2020	(1)	Common Stock	104000	(1)	0	D

Explanation of Responses:

(1)

104,000 shares represent vesting of Performance Stock Units disclosed in the Form 8-K Current Report dated February 24, 2015 as determined by the January 31, 2020 Compensation Committee certification that CONMED total shareholder return for the five year performance period outperformed the S&P 1500 Health Care Equipment Select Index (the "Index") with performance of 106.07% relative to the Index, resulting in an award of 104,000 shares, with the Company withholding 48,903 shares for payment of withholding taxes.

Reporting Owners
Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
Hartman Curt R C/O CONMED CORP 525 FRENCH ROAD UTICA, NY 13502	X		President & CEO

Signatures
/s/ Daniel S. Jonas for Curt R. Hartman by Power of Attorney		2/4/2020
**Signature of Reporting Person		Date